Roswell Park Cancer Institute: all 417 studies

Page 1 of 5. Open to participants first (64), then studies with results posted, then the rest; newest registration first within each.

• Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic CounselingNot yet recruitingNCT07887620Not applicable
• Mind-Body Interventions for the Improvement of Quality of Life, Stress, and Sleep Quality Among Survivors of Breast, Prostate, Endometrial, or Colorectal CancerNot yet recruitingNCT07745023Not applicable
• Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung CancerRecruitingNCT07718672Phase 2
• Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active SurveillanceRecruitingNCT07714018Not applicable
• Bispecific CD19/CD20-Targeted Chimeric Antigen Receptor (CAR) Modified T Cells With 4-1BB and Mutated CD28 Costimulatory Domains in Patients With Relapsed or Refractory CD19+ Hematologic MalignanciesNot yet recruitingNCT07701889Phase 1
• Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative NeoplasmsNot yet recruitingNCT07679334Phase 1
• Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette SmokersNot yet recruitingNCT07553819Not applicable
• CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung CancerNot yet recruitingNCT07543172Phase 2
• GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube CancerRecruitingNCT07489287Phase 1
• Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and MaintenanceRecruitingNCT07439471
• Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility StudyRecruitingNCT07402577
• Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07214298Phase 1/2
• Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell CarcinomasRecruitingNCT07182240Not applicable
• Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use Cigarettes, E-cigarettes and Cannabis (Co-Tox Study)RecruitingNCT07167225
• Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective EffectsRecruitingNCT07107139Not applicable
• Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product DemandRecruitingNCT07102082Not applicable
• Transperineal Micro-ultrasound for the Detection of Prostate Cancer During BiopsyRecruitingNCT07075705Not applicable
• GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung CancerRecruitingNCT07017829Phase 2
• Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRecruitingNCT06995508Phase 2
• Electrotherapy Stimulation Together With Life Coaching for the Support of Burnout Symptoms in Healthcare WorkersRecruitingNCT06977503Not applicable
• A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass TrialRecruitingNCT06896695Not applicable
• Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT06871410Phase 1
• New York Better Breathing StudyRecruitingNCT06869447Not applicable
• Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma SubtypeRecruitingNCT06863402Phase 2
• An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 StudyRecruitingNCT06855706Not applicable
• A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New YorkRecruitingNCT06833255Not applicable
• Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring OpioidsNot yet recruitingNCT06827054Phase 2
• NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar TrialRecruitingNCT06821997Phase 2
• Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking AdultsRecruitingNCT06816459Early Phase 1
• A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder CancerRecruitingNCT06733363Phase 2
• Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active SurveillanceRecruitingNCT06733350Phase 4
• A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New YorkRecruitingNCT06681077Not applicable
• Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary DiseaseRecruitingNCT06627751Phase 2
• SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT06622005Phase 1
• Community-Based Exercise and Nutrition Training and Education Program for Cancer SurvivorsRecruitingNCT06565260Not applicable
• Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialRecruitingNCT06563388Phase 3
• Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast CancerRecruitingNCT06434064Phase 2
• A Patient Navigation Program for Addressing Disparities in Breast Cancer CareRecruitingNCT06350500Not applicable
• Evaluating the Delivery and Effects of THC Vaping Liquids in the BloodstreamNot yet recruitingNCT06334016Early Phase 1
• MedSupport Intervention to Identify and Address Barriers to Pediatric Medication AdherenceRecruitingNCT06323044Not applicable
• AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal AdenocarcinomaRecruitingNCT06320717
• Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal CancerRecruitingNCT06307548Phase 1/2
• Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway ObstructionRecruitingNCT06306638Phase 1/2
• Community-Based Physical Activity Intervention for Underserved Cancer SurvivorsRecruitingNCT06206863Not applicable
• Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine CarcinomasNot yet recruitingNCT06202066Phase 2
• Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3RecruitingNCT06074666Not applicable
• PK/PD of Vaping THC-containing Liquids vs. Smoked CannabisNot yet recruitingNCT06055231Phase 1
• Low-Intensity Mechanical Stimulation for Hematologic Malignancy PatientsRecruitingNCT05893940Not applicable
• Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for CancerRecruitingNCT05787834Not applicable
• Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction AdenocarcinomaRecruitingNCT05651594Phase 2
• Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple MyelomaRecruitingNCT05312255Not applicable
• Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerRecruitingNCT05292521Not applicable
• Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian CancerRecruitingNCT05231122Phase 2
• APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant EffusionRecruitingNCT04919629Phase 2
• Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung CancerRecruitingNCT04696575Phase 2
• Propranolol With Chemotherapy or Chemoradiation for Esophageal AdenocarcinomaRecruitingNCT04682158Phase 2
• Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 InhibitorsRecruitingNCT04526587
• Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerRecruitingNCT04511039Phase 1
• Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast CancerRecruitingNCT04348747Phase 2
• Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic CancerRecruitingNCT04068649Phase 2
• Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerRecruitingNCT04067830Phase 2
• Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesRecruitingNCT03965234Phase 1/2
• Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy SubjectsRecruitingNCT03897270Not applicable
• Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate CancerRecruitingNCT03880422Not applicable
• A Sugar-Sweetened Beverage Reduction Intervention for Native American MenCompletedNCT06029517Not applicableResults posted
• Effects of Tobacco Flavoring and Liquid Composition on Vaping TopographyTerminatedNCT05876091Not applicableResults posted
• Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast CancerTerminatedNCT05756166Phase 1/2Results posted
• Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery SystemsCompletedNCT05423340Not applicableResults posted
• Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette SmokersCompletedNCT04744285Not applicableResults posted
• Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer ScreeningCompletedNCT04607291Phase 1Results posted
• Behavioral Dietary Intervention for the Improvement of Bladder Cancer SurvivorshipCompletedNCT04548193Phase 1Results posted
• Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical CystectomyCompletedNCT04502095Phase 4Results posted
• Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer PatientsTerminatedNCT04379518Phase 1/2Results posted
• CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years OldCompletedNCT04269213Phase 2Results posted
• Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE StudyCompletedNCT04231539Not applicableResults posted
• TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO StudyCompletedNCT04109924Phase 2Results posted
• Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04097028Phase 2Results posted
• Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory MelanomaTerminatedNCT04093323Phase 2Results posted
• Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerCompletedNCT04081389Phase 1Results posted
• Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung CancerActive, not recruitingNCT04032418Phase 2Results posted
• Palliative Management of Inoperable Malignant Bowel ObstructionTerminatedNCT04027348Phase 2Results posted
• Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic SurgeriesTerminatedNCT04000581Not applicableResults posted
• Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell TransplantCompletedNCT03925532Phase 2Results posted
• Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic OriginTerminatedNCT03736720Phase 2Results posted
• Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung CancerCompletedNCT03735095Phase 1/2Results posted
• Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerTerminatedNCT03727061Phase 1Results posted
• Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation TherapyCompletedNCT03574792Phase 2Results posted
• Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-ACCompletedNCT03567850Not applicableResults posted
• Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to ChemotherapyTerminatedNCT03457142Phase 2Results posted
• Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT03403634Phase 2Results posted
• DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT03358719Phase 1Results posted
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerTerminatedNCT03333486Phase 2Results posted
• Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver CancerCompletedNCT03211416Phase 1/2Results posted
• Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantActive, not recruitingNCT03192397Phase 1/2Results posted
• Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity CancerTerminatedNCT03090412Phase 2Results posted
• Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal CancerCompletedNCT02965976Phase 2Results posted
• Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 MutationCompletedNCT02953457Phase 2Results posted
• Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02853318Phase 2Results posted
• Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02713373Phase 1/2Results posted
• Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1Active, not recruitingNCT02650986Phase 1/2Results posted

← Roswell Park Cancer Institute overview and focus areas